Therapeutic Use of Tolvaptan in Cancer-Related Hyponatremia: Benefits, Risks, and Clinical Guidance. (2026). International Journal of Emerging Research in Applied Medical Sciences, 2(4), 10-18. https://doi.org/10.65477/j29hcv64